Unilever PLC (FRA:UNVB)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	129,505	136,147	109,432	119,234	120,277	128,674
Market Cap Growth	0.55%	24.41%	-8.22%	-0.87%	-6.53%	-5.02%
Enterprise Value	157,818	164,810	136,198	148,432	145,788	154,546
Last Close Price	52.24	54.21	41.65	43.36	41.76	41.93
PE Ratio	23.31	23.70	16.87	15.60	19.88	23.06
PS Ratio	2.17	2.24	1.84	1.99	2.29	2.54
PB Ratio	6.50	6.04	5.27	5.49	6.09	7.29
P/FCF Ratio	-	17.50	13.81	20.47	17.52	15.70
P/OCF Ratio	-	14.30	11.61	16.37	15.09	14.21
EV/Sales Ratio	2.68	2.71	2.29	2.47	2.78	3.05
EV/EBITDA Ratio	12.75	13.42	12.26	13.21	12.81	13.59
EV/EBIT Ratio	14.37	14.65	13.46	15.61	15.13	16.52
EV/FCF Ratio	23.84	21.18	17.19	25.48	21.24	18.86
Debt / Equity Ratio	1.61	1.42	1.43	1.36	1.53	1.55
Debt / EBITDA Ratio	2.60	2.53	2.57	2.62	2.65	2.40
Debt / FCF Ratio	4.84	4.12	3.74	5.06	4.39	3.33
Asset Turnover	0.77	0.78	0.78	0.79	0.74	0.77
Inventory Turnover	6.00	6.49	6.23	6.77	6.62	6.65
Quick Ratio	0.53	0.50	0.46	0.44	0.36	0.52
Current Ratio	0.77	0.76	0.76	0.75	0.70	0.79
Return on Equity (ROE)	28.70%	29.40%	33.63%	39.90%	35.41%	38.51%
Return on Assets (ROA)	8.75%	9.07%	8.26%	7.78%	8.44%	8.83%
Return on Capital (ROIC)	12.79%	13.39%	12.45%	11.76%	12.70%	13.43%
Return on Capital Employed (ROCE)	21.40%	20.60%	19.60%	18.20%	19.20%	19.90%
Earnings Yield	4.29%	4.22%	5.93%	6.41%	5.03%	4.34%
FCF Yield	5.11%	5.71%	7.24%	4.89%	5.71%	6.37%
Dividend Yield	3.42%	3.30%	4.09%	3.84%	4.16%	3.94%
Payout Ratio	79.96%	75.19%	67.26%	56.65%	74.11%	76.67%
Buyback Yield / Dilution	1.24%	1.00%	1.07%	1.91%	0.77%	-0.12%
Total Shareholder Return	4.71%	4.30%	5.16%	5.75%	4.93%	3.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.